BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32252517)

  • 41. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracellular pH-sensitive PEG-block-acetalated-dextrans as efficient drug delivery platforms.
    Zhang Z; Chen X; Chen L; Yu S; Cao Y; He C; Chen X
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):10760-6. PubMed ID: 24090231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic-Chemo Combination Therapy.
    Yang DC; Wang S; Weng XL; Zhang HX; Liu JY; Lin Z
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33905-33914. PubMed ID: 34278780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.
    Gao Y; Li Y; Li Y; Yuan L; Zhou Y; Li J; Zhao L; Zhang C; Li X; Liu Y
    Nanoscale; 2015 Jan; 7(2):597-612. PubMed ID: 25419788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
    Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
    J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperthermia Nanofiber Platform Synergized by Sustained Release of Paclitaxel to Improve Antitumor Efficiency.
    Niiyama E; Uto K; Lee CM; Sakura K; Ebara M
    Adv Healthc Mater; 2019 Jul; 8(13):e1900102. PubMed ID: 31091019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly.
    Zhu JY; Lei Q; Yang B; Jia HZ; Qiu WX; Wang X; Zeng X; Zhuo RX; Feng J; Zhang XZ
    Biomaterials; 2015 Jun; 52():281-90. PubMed ID: 25818434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.
    Fan W; Wang Y; Dai X; Shi L; Mckinley D; Tan C
    Pharm Res; 2015 Apr; 32(4):1325-40. PubMed ID: 25319102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
    Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    Ji W; Wang B; Fan Q; Xu C; He Y; Chen Y
    PLoS One; 2017; 12(7):e0180037. PubMed ID: 28686704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing the Anticancer Activity and Selectivity of Goniothalamin Using pH-Sensitive Acetalated Dextran (Ac-Dex) Nanoparticles: A Promising Platform for Delivery of Natural Compounds.
    Braga CB; Kido LA; Lima EN; Lamas CA; Cagnon VHA; Ornelas C; Pilli RA
    ACS Biomater Sci Eng; 2020 May; 6(5):2929-2942. PubMed ID: 33463303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
    Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
    J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.